medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
    • Políticas éticas
    • Políticas editoriales generales
    • Políticas de revisión de manuscritos
    • Políticas de acceso abierto
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 1

<< Back Next >>

Rev Mex Pediatr 2026; 93 (1)

Autosomal dominant type 2 elliptocytosis

Sánchez-Pinzón CA, Atencia-Herrera CM, Sánchez-Tordecilla MM, Puerta-Lara MC, Corredor-Motta JP
Full text How to cite this article 10.35366/123108

DOI

DOI: 10.35366/123108
URL: https://dx.doi.org/10.35366/123108

Language: Spanish
References: 23
Page: 36-40
PDF size: 756.77 Kb.


Key words:

hereditary elliptocytosis, hemolytic anemia, newborn, SPTA1 gene.

ABSTRACT

Introduction: hereditary elliptocytosis (HE) is a rare disorder of the erythrocyte membrane, with wide clinical and genetic heterogeneity. Although most patients have a mild course, some may present severe hemolytic anemia from the neonatal period. We present the case of a pediatric patient with autosomal dominant type 2 HE, treated in Cartagena, Colombia. Case description: a male infant presented in the neonatal period with severe hemolytic anemia, jaundice, and recurrent transfusion requirements. Initial studies ruled out immunological and infectious causes. The peripheral blood smear showed poikilocytosis and morphological alterations suggestive of erythrocyte membrane abnormalities. As part of the diagnostic workup, molecular analysis was performed using a genetic panel, identifying a heterozygous pathogenic variant in the SPTA1 gene (NM_003126.2:c.83G>A; p.Arg28His), thus confirming the diagnosis. The patient has experienced episodes of hemolysis related to respiratory infections but has maintained adequate growth and development. Conclusions: type 2 HE should be considered in the differential diagnosis of neonatal non-immune hemolytic anemia. Genetic testing is essential for diagnostic confirmation.


REFERENCES

  1. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008; 112(10): 3939-3948. doi: 10.1182/blood-2008-07-161166.

  2. Mohandas N. Inherited hemolytic anemia: a possessive beginner's guide. Hematology Am Soc Hematol Educ Program. 2018; 2018(1): 377-381. doi: 10.1182/asheducation-2018.1.377.

  3. Franck P, Postma C, Spaans A, Veuger M, de Kort G, Hudig C et al. Hereditary elliptocytosis: variable clinical severity caused by three variants in the alpha-spectrin gene. Int J Lab Hematol. 2018; 40(4): e66-e70. doi: 10.1111/ijlh.12837.

  4. Gallagher PG. Hereditary elliptocytosis: spectrin and protein 4.1R. Semin Hematol. 2004; 41(2): 142-164. doi: 10.1053/j.seminhematol.2004.01.003.

  5. Coetzer T, Lawler J, Prchal JT, Palek J. Molecular determinants of clinical expression of hereditary elliptocytosis and pyropoikilocytosis. Blood. 1987; 70(3): 766-772.

  6. Costa DB, Lozovatsky L, Gallagher PG, Forget BG. A novel splicing mutation of the alpha-spectrin gene in the original hereditary pyropoikilocytosis kindred. Blood. 2005; 106(13): 4367-4369. doi: 10.1182/blood-2005-05-1813.

  7. Dhermy D, Garbarz M, Lecomte MC, Feo C, Bournier C, Chaveroche I et al. Hereditary elliptocytosis: clinical, morphological and biochemical studies of 38 cases. Nouv Rev Fr Hematol. 1986; 28: 129-140.

  8. Glele-Kakai C, Garbarz M, Lecomte MC, Leborgne S, Galand C, Bournier O et al. Epidemiological studies of spectrin mutations related to hereditary elliptocytosis and spectrin polymorphisms in Benin. Br J Haematol. 1996; 95(1): 57-66. doi: 10.1046/j.1365-2141.1996.d01-1869.x.

  9. Dhermy D, Schrével J, Lecomte MC. Spectrin-based skeleton in red blood cells and malaria. Curr Opin Hematol. 2007; 14(3): 198-202. doi: 10.1097/MOH.0b013e3280d21afd.

  10. Bayhan T, Unal S, Gümrük F. Hereditary elliptocytosis with pyropoikilocytosis. Turk J Haematol. 2016; 33(1): 86-87. doi: 10.4274/tjh.2015.0054.

  11. Zaidi AU, Buck S, Gadgeel M, Herrera-Martinez M, Mohan A, Johnson K et al. Clinical diagnosis of red cell membrane disorders: comparison of osmotic gradient ektacytometry and eosin-5-maleimide fluorescence test for red cell band 3 (AE1, SLC4A1) content. Front Physiol. 2020; 11: 636. doi: 10.3389/fphys.2020.00636.

  12. Gallagher PG. Red cell membrane disorders. Hematology Am Soc Hematol Educ Program. 2005; 13-18. doi: 10.1182/asheducation-2005.1.13.

  13. Jha SK, Vaqar S. Hereditary elliptocytosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

  14. Morrow JS, Rimm DL, Kennedy SP, Cianci CD, Sinard JH, Weed SA. Of membrane stability and mosaics: the spectrin cytoskeleton. Compr Physiol. 1997; 485-540. doi: 10.1002/cphy.cp140111.

  15. Gaetani M, Mootien S, Harper S, Gallagher PG, Speicher DW. Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha-spectrin tetramer site. Blood. 2008; 111(12): 5712-5720. doi: 10.1182/blood-2007-11-122457.

  16. Ipsaro JJ, Harper SL, Messick TE, Marmorstein R, Mondragón A, Speicher DW. Crystal structure and functional interpretation of the erythrocyte spectrin tetramerization domain complex. Blood. 2010; 115(23): 4843-4852. doi: 10.1182/blood-2010-01-261396.

  17. Coetzer T, Palek J, Lawler J, Liu SC, Jarolim P, Lahav M et al. Structural and functional heterogeneity of alpha-spectrin mutations involving the spectrin heterodimer self-association site: relationships to hematologic expression of homozygous hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood. 1990; 75(11): 2235-2244.

  18. Liu C, Eun HS, Nah H, Lee ST, Choi JR, Kim HO. Newborn hereditary elliptocytosis confirmed by familial genetic testing. Int J Lab Hematol. 2020; 42(1): e20-e22. doi: 10.1111/ijlh.13079.

  19. Jiang S, Lu R, Tang J. A rare case report of hemolysis in a newborn: hereditary elliptocytosis. Front Pediatr. 2024; 12: 1485318. doi: 10.3389/fped.2024.1485318.

  20. Pang L, Zeng Z, Ding Y, Huang H, Li H. Case report: whole-exome sequencing for a hereditary elliptocytosis case with unexpectedly low HbA1c. Front Med (Lausanne). 2023; 10: 1301760. doi: 10.3389/fmed.2023.1301760.

  21. Moreno Toro N, Gámez Belmonte A, Alperi García S, Morillas Mingorance A, Ortega Acosta MJ, Urrutia Maldonado E et al. Hereditary elliptocytosis: A novel mutation in the SPTA1 gene and diagnosis after a stroke in paediatric patients. A two-case report. Pediatr Blood Cancer. 2023; 70(7): e30316. doi: 10.1002/pbc.30316.

  22. Shome DK, Das P, Akbar GA, Taha S, Radhi A, Al-Saad K et al. Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes. Ann Hematol. 2023; 102(9): 2343-2351. doi: 10.1007/s00277-023-05337-9.

  23. Zarkowsky HS, Mohandas N, Speaker CB, Shohet SB. A congenital haemolytic anaemia with thermal sensitivity of the erythrocyte membrane. Br J Haematol. 1975; 29(4): 537-543. doi: 10.1111/j.1365-2141.1975.tb02740.x.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2026;93